Cargando…
CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line
OBJECTIVE: Cutaneous melanoma is the most hazardous malignancy of skin cancer with a high mortality rate. It has been reported that cancer stem cells (CSCs) are responsible for malignancy in most of cancers including melanoma. The aim of this study is to compare two common methods for melanoma stem...
Autores principales: | Rajabi Fomeshi, Motahareh, Ebrahimi, Marzieh, Mowla, Seyed Javad, Firouzi, Javad, Khosravani, Pardis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819382/ https://www.ncbi.nlm.nih.gov/pubmed/27054115 |
Ejemplares similares
-
An Integrative Analysis of The Micro-RNAs Contributing in
Stemness, Metastasis and B-Raf Pathways in Malignant
Melanoma and Melanoma Stem Cell
por: Sahranavardfard, Parisa, et al.
Publicado: (2021) -
Histone Modification Marks Strongly Regulate CDH1 Promoter in
Prostospheres as A Model of Prostate Cancer Stem Like Cells
por: Shokraii, Fatemeh, et al.
Publicado: (2019) -
Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma
por: Korn, Philippe, et al.
Publicado: (2021) -
NK cell upraise in the dark world of cancer stem cells
por: Shokouhifar, Alireza, et al.
Publicado: (2021) -
Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)